Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Colorectal Neoplasms

Free Subscription Articles published in Cancer Retrieve available abstracts of 63 articles: HTML format

Single Articles

September 2026
1. ZAVOS C
   Interpreting a borderline signal in colorectal cancer screening among sexual and gender minority adults.
   Cancer. 2026;132:e70598.
   PubMed    
   
   
   August 2026
2. DIRVEN I, Ang C, Bertels C, Kortbeek K, et al
   The past, present, and future treatment of BRAF(V600)-mutant metastatic colorectal cancer: A comprehensive review.
   Cancer. 2026;132:e70569.
   PubMed     Abstract available
   
   
   July 2026
3. ARENA L, Alizai Q, Elemosho A, Chatzipanagiotou OP, et al
   Sexual orientation and gender identity based disparities in colorectal, cervical, and breast cancer screening in the United States.
   Cancer. 2026;132:e70462.
   PubMed     Abstract available
   
   
   
4. 
   Trial shows no DFS benefit from neoadjuvant chemotherapy versus upfront surgery in locally advanced colon cancer.
   Cancer. 2026;132:e70474.
   PubMed    
   
   
   
5. SIDDIQUE S, Wang R, Berardi D, Johnson CH, et al
   Demographic, birth, parental characteristics, and the risk of early-onset colorectal cancer: A population-based nested case-control study in California.
   Cancer. 2026;132:e70458.
   PubMed     Abstract available
   
   
   June 2026
6. LORONA NC, LaBrie S, Thomas CE, Yin H, et al
   Site- and age-dependent associations between Fusobacterium nucleatum and colorectal cancer mortality.
   Cancer. 2026;132:e70484.
   PubMed     Abstract available
   
   
   
7. MILLER ED, Jethwa KR, Dozois E, Jin Z, et al
   Executive summary of American Radium Society Appropriate Use Criteria for the treatment of locoregionally recurrent rectal cancer.
   Cancer. 2026;132:e70464.
   PubMed     Abstract available
   
   
   
8. KONDO KK, Shiau RL, Troutman CAB, Griffin JC, et al
   Blood-based cell-free DNA and multitarget stool RNA screening tests to detect colorectal cancer: A systematic review.
   Cancer. 2026;132:e70428.
   PubMed     Abstract available
   
   
   May 2026
9. TANGKA FKL, Subramanian S, Hoover S, O'Rourke K, et al
   Cost-effectiveness of interventions to increase colorectal cancer screening among populations with low screening uptake.
   Cancer. 2026;132:e70436.
   PubMed     Abstract available
   
   
   
10. LAWRENCE L
    GLP-1 RAs could reduce risk of developing colorectal cancer.
    Cancer. 2026;132:e70367.
    PubMed    
    
    
    
11. LAWRENCE L
    Two trials bring new advances for patients with metastatic colorectal cancer: First-line data show longer disease control in MSI-H/dMMR and higher responses in BRAF V600E.
    Cancer. 2026;132:e70368.
    PubMed    
    
    
    April 2026
12. BARRY KH, Loftfield E
    Reply to "Interpreting lifetime alcohol intake and colorectal cancer risk".
    Cancer. 2026;132:e70424.
    PubMed    
    
    
    
13. TARASEWICZ M, Kazberuk M, Zbroch E, Markowski AR, et al
    Interpreting lifetime alcohol intake and colorectal cancer risk.
    Cancer. 2026;132:e70426.
    PubMed    
    
    
    
14. OBA S, Okuno K, Watanabe S, Yamamoto Y, et al
    Intratumoral fungal burden of Candida tropicalis as a novel prognostic biomarker for recurrence and mortality in colorectal cancer.
    Cancer. 2026;132:e70408.
    PubMed     Abstract available
    
    
    
15. VAN TUIJL LA, Pan KY, Basten M, Vermeulen R, et al
    Psychosocial factors and the risk of cancer: An individual-participant data meta-analysis.
    Cancer. 2026;132:e70271.
    PubMed     Abstract available
    
    
    February 2026
16. 
    Correction to "Association of alcohol intake over the lifetime with colorectal adenoma and colorectal cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial".
    Cancer. 2026;132:e70324.
    PubMed    
    
    
    
17. O'CONNELL CP, Berndt SI, Chudy-Onwugaje K, Kunzmann A, et al
    Association of alcohol intake over the lifetime with colorectal adenoma and colorectal cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Cancer. 2026;132:e70201.
    PubMed     Abstract available
    
    
    January 2026
18. ALATISE OI, Owoade IA, Fayenuwo OJ, Lawal NOO, et al
    Customized early detection of colorectal cancer in Nigeria identifies advanced adenomas and early-stage disease.
    Cancer. 2026;132:e70156.
    PubMed     Abstract available
    
    
    December 2025
19. FANG J, Zheng Z, Chen T, Liu J, et al
    Efficacy and safety of PD-L1 blockade envafolimab as neoadjuvant treatment in mismatch repair-deficient, locally advanced colorectal cancer: An open-label, single-arm study.
    Cancer. 2025;131:e70203.
    PubMed     Abstract available
    
    
    
20. MYERS S, Davis ES, Franks JA, Davids JS, et al
    Beyond composite measures of regional vulnerability: Rural-urban colorectal cancer mortality disparities mediated by area-level characteristics.
    Cancer. 2025;131:e70098.
    PubMed     Abstract available
    
    
    October 2025
21. FOLKERTS AD, Janczewski LM, Merkow RP
    Liver-directed therapies for colorectal liver metastases.
    Cancer. 2025;131:e70097.
    PubMed     Abstract available
    
    
    
22. CORONADO GD, Gautom P, Schneider JL, Edelmann AC, et al
    Multilevel challenges and adaptations to patient navigation programs for colorectal cancer screening and follow-up: Findings from the Accelerating Colorectal Cancer Screening and follow-up through Implementation Science consortium.
    Cancer. 2025;131:e70121.
    PubMed     Abstract available
    
    
    
23. BUCHLER T, Ambrozova M, Majek O, Dianova T, et al
    Risk of second primary malignancies after adjuvant chemotherapy for colon cancer.
    Cancer. 2025;131:e70116.
    PubMed     Abstract available
    
    
    
24. KO B, Rojanasopondist P, Grady WM
    Top advances of the year: Noninvasive colorectal cancer screening tests.
    Cancer. 2025;131:e70115.
    PubMed     Abstract available
    
    
    September 2025
25. STEVENS SX, Gyawali B
    CodeBreaK or code blue? Assessing sotorasib's vital signs in metastatic colorectal cancer.
    Cancer. 2025;131:e70056.
    PubMed     Abstract available
    
    
    August 2025
26. TANGKA FKL, Ruiz E, Ibarra R, Hudson SM, et al
    Effectiveness and cost of implementing a patient navigation program to increase colorectal cancer screening in a large federally qualified health center.
    Cancer. 2025;131:e70031.
    PubMed     Abstract available
    
    
    
27. NIERENGARTEN MB
    Colorectal cancer treatments show promise: Studies find longer progression-free survival and a potential relative reduction in the risk of death with treatment advances.
    Cancer. 2025;131:e70000.
    PubMed    
    
    
    July 2025
28. SCHULTZ KS, Bansal VV, Wach MM, Bhutiani N, et al
    Consensus guideline for the management of colorectal cancer with peritoneal metastases.
    Cancer. 2025;131:e35869.
    PubMed     Abstract available
    
    
    May 2025
29. NIERENGARTEN MB
    Potential new standard of care for the first-line treatment of metastatic colorectal cancer: Interim analyses showed significantly better progression-free survival outcomes with the combination regimen versus either chemotherapy alone or nivolumab alo
    Cancer. 2025;131:e35854.
    PubMed    
    
    
    
30. STIMPSON JP, Liao JM, Morenz AM, Joo JH, et al
    A difference-in-differences analysis of Medicaid expansion and state paid sick leave laws on colorectal cancer screening.
    Cancer. 2025;131:e35904.
    PubMed     Abstract available
    
    
    
31. NIERENGARTEN MB
    Calcium may help to protect against colorectal cancer.
    Cancer. 2025;131:e35827.
    PubMed    
    
    
    
32. LEE S, Ma C, Caan BJ, Binder AM, et al
    Impact of resistance training on inflammatory biomarkers and associations with treatment outcomes in colon cancer.
    Cancer. 2025;131:e35865.
    PubMed     Abstract available
    
    
    April 2025
33. SUAREZ-RAMOS T, Verganza S, Pagan-Santana Y, Castaneda-Avila MA, et al
    Evaluating the impact of hurricanes and the COVID-19 pandemic on colorectal cancer incidence in Puerto Rico: An interrupted time-series analysis.
    Cancer. 2025;131:e35793.
    PubMed     Abstract available
    
    
    
34. MACHIDA N, Okumura T, Boku N, Kishimoto J, et al
    A phase 2 study of adjuvant chemotherapy with 5-fluorouracil/leucovorin and oxaliplatin after lung metastasectomy for colorectal cancer (WJOG5810G).
    Cancer. 2025;131:e35807.
    PubMed     Abstract available
    
    
    
35. CLARKE N, Mooney T, Gallagher P, von Wagner C, et al
    Interventions to increase uptake in a fecal-immunochemical test population-based colorectal cancer screening program: A quasi-experimental study of first-time invitees.
    Cancer. 2025;131:e35760.
    PubMed     Abstract available
    
    
    March 2025
36. RAYCHAUDHURI S, McLaughlin E, Pennell ML, Stefanick M, et al
    The relationship between cardiometabolic abnormalities and mortality in the Women's Health Initiative: A comparison of associations among women with cancer to women without cancer.
    Cancer. 2025;131:e35804.
    PubMed     Abstract available
    
    
    
37. VOGTMANN E, Yano Y, Zouiouich S, Hua X, et al
    The human oral microbiome and risk of colorectal cancer within three prospective cohort studies in the United States.
    Cancer. 2025;131:e35802.
    PubMed     Abstract available
    
    
    
38. BROWN JC, Ma C, Shi Q, Saltz LB, et al
    The association of physical activity with survival in colon cancer versus a matched general population: Data from Cancer and Leukemia Group B 89803 and 80702 (Alliance).
    Cancer. 2025;131:e35727.
    PubMed     Abstract available
    
    
    February 2025
39. ESLINGER C, Walden D, McGary A, Emiloju O, et al
    Comparison of survival outcomes for patients with Lynch vs non-Lynch syndrome and microsatellite unstable colorectal cancer treated with immunotherapy.
    Cancer. 2025;131:e35756.
    PubMed     Abstract available
    
    
    
40. BAEKER BISPO J, Jemal A, Islami F
    Association of mental health treatment receipt with cancer screening among US adults with a history of anxiety or depression.
    Cancer. 2025;131:e35724.
    PubMed     Abstract available
    
    
    January 2025
41. PASSMAN JE, Kallan MJ, Roberson JL, Ginzberg SP, et al
    Contemporary trends in utilization of metastasectomy in the era of targeted and immunotherapies.
    Cancer. 2025;131:e35664.
    PubMed     Abstract available
    
    
    
42. NORIEGA ESQUIVES BS, Moreno PI, Munoz E, Lad TE, et al
    Effects of a culturally tailored patient navigation program on unmet supportive care needs in Hispanic/Latino cancer survivors: A randomized controlled trial.
    Cancer. 2025;131:e35626.
    PubMed     Abstract available
    
    
    
43. PANDEY AS, Drogan C, Huo D, Postula K, et al
    Anticipation in families with MLH1-associated Lynch syndrome.
    Cancer. 2025;131:e35589.
    PubMed     Abstract available
    
    
    December 2024
44. NIERENGARTEN MB
    Colorectal cancer screening and prevention: Efforts aim to optimize colonoscopy measures and broaden accessibility to screening in underserved areas.
    Cancer. 2024;130:3945.
    PubMed    
    
    
    November 2024
45. CHAI TS, Rodgers-Fouche LH, Walls JO, Mattia AR, et al
    Real-world genetic testing outcomes of pan-cancer testing for mismatch repair deficiency.
    Cancer. 2024;130:3888-3893.
    PubMed     Abstract available
    
    
    
46. DESAI P, Zhou Y, Grenet J, Handelman SK, et al
    Association of clonal hematopoiesis and mosaic chromosomal alterations with solid malignancy incidence and mortality.
    Cancer. 2024;130:3879-3887.
    PubMed     Abstract available
    
    
    October 2024
47. COMPTON SLE, Yang S, Madere J, Weltzien EK, et al
    Dietary quality and chemotherapy-induced peripheral neuropathy in colon cancer.
    Cancer. 2024 Oct 5. doi: 10.1002/cncr.35599.
    PubMed     Abstract available
    
    
    
48. SHI KS, Han X, Star J, Zhao J, et al
    Association of health insurance coverage disruptions and breast and colorectal cancer screening.
    Cancer. 2024 Oct 1. doi: 10.1002/cncr.35584.
    PubMed     Abstract available
    
    
    September 2024
49. BHUTIANI N, Peacock O, Uppal A, Hu CY, et al
    The prognostic impact of tumor deposits in colorectal cancer: More than just N1c.
    Cancer. 2024 Sep 22. doi: 10.1002/cncr.35491.
    PubMed     Abstract available
    
    
    
50. HE MM, Wang K, Song M
    Reply to "The influence of multivitamin intake on survival patterns in patients with colorectal cancer".
    Cancer. 2024 Sep 15. doi: 10.1002/cncr.35569.
    PubMed    
    
    
    
51. TANG WZ, Tang Y, Liu TH
    The influence of multivitamin intake on survival patterns in patients with colorectal cancer.
    Cancer. 2024 Sep 14. doi: 10.1002/cncr.35570.
    PubMed    
    
    
    August 2024
52. BEATRICI E, Paciotti M, Nguyen DD, Filipas DK, et al
    Estimating the impact of enhanced care at minority-serving hospitals on disparities in the treatment of breast, prostate, lung, and colon cancers.
    Cancer. 2024;130:2770-2781.
    PubMed     Abstract available
    
    
    
53. ISSAKA RB, Ibekwe LN, Todd KW, Burnett-Hartman AN, et al
    Association between racial residential segregation and screening uptake for colorectal and cervical cancer among Black and White patients in five US health care systems.
    Cancer. 2024 Aug 9. doi: 10.1002/cncr.35514.
    PubMed     Abstract available
    
    
    
54. NIERENGARTEN MB
    Potential new therapy for KRAS-mutated CRC.
    Cancer. 2024;130:2569.
    PubMed    
    
    
    July 2024
55. SUN V, Guthrie KA, Crane TE, Arnold KB, et al
    SWOG S1820: A pilot randomized trial of the Altering Intake, Managing Bowel Symptoms Intervention in Survivors of Rectal Cancer.
    Cancer. 2024;130:2384-2394.
    PubMed     Abstract available
    
    
    May 2024
56. MARTINEZ ME, Roesch S, Largaespada V, Castaneda SF, et al
    A pragmatic randomized trial of mailed fecal immunochemical testing to increase colorectal cancer screening among low-income and minoritized populations.
    Cancer. 2024 May 25. doi: 10.1002/cncr.35369.
    PubMed     Abstract available
    
    
    
57. HOEHN RS, Ammori JB, Rothermel LD, Winter JM, et al
    Providing context for the HIPECT4 results.
    Cancer. 2024;130:1727-1729.
    PubMed    
    
    
    
58. JANCZEWSKI LM, Browner A, Cotler J, Nelson H, et al
    Data-driven optimization of version 9 American Joint Committee on Cancer staging system for anal cancer.
    Cancer. 2024;130:1702-1710.
    PubMed     Abstract available
    
    
    April 2024
59. SIMONI O, Scarpa M, Castagliuolo I, Stepanyan A, et al
    IMMUNOREACT 7: Regular aspirin use is associated with immune surveillance activation in colorectal cancer.
    Cancer. 2024 Apr 22. doi: 10.1002/cncr.35297.
    PubMed     Abstract available
    
    
    
60. STERPETTI AV, Gabriele R, Iannone I, Dimarzo L, et al
    National organized screening programs for breast, colorectal, and cervical cancer reduce socioeconomic disparities, but it is not enough.
    Cancer. 2024 Apr 20. doi: 10.1002/cncr.35335.
    PubMed    
    
    
    
61. RUAN Y, Heer E, Brenner DR
    Reply to "National organized screening programs for breast, colorectal, and cervical cancer reduce socioeconomic disparities, but it is not enough".
    Cancer. 2024 Apr 20. doi: 10.1002/cncr.35339.
    PubMed    
    
    
    February 2024
62. LIU YL, Weigelt B
    A tale of two pathways: Review of immune checkpoint inhibitors in DNA mismatch repair-deficient and microsatellite instability-high endometrial cancers.
    Cancer. 2024 Feb 29. doi: 10.1002/cncr.35267.
    PubMed     Abstract available
    
    
    November 2023
63. YANG K, Doege D, Thong MSY, Koch-Gallenkamp L, et al
    Diabetes mellitus in long-term survivors with colorectal, breast, or prostate cancer: Prevalence and prognosis. A population-based study.
    Cancer. 2023 Nov 23. doi: 10.1002/cncr.35133.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum